Tag: VNS Therapy
Tivic completes enrolment in study of non-invasive, bioelectronic VNS therapy
Tivic Health Systems has announced that enrolment in its pilot clinical study of a proprietary approach to non-invasive vagus nerve stimulation (VNS) has been completed....
Brain stimulation plus rehabilitation produces improved upper-limb function in stroke survivors
Combining brain stimulation with intense physical rehabilitation helped stroke survivors recover movement in their arms and hands, and maintain these improvements for one year, within a...
LivaNova announces randomisation of 150th bipolar depression patient in RECOVER clinical...
LivaNova has announced that the 150th bipolar depression patient has been randomised in its RECOVER clinical study—a prospective, multicentre, double-blinded randomised controlled trial investigating...
RECOVER trial will provide “thorough understanding” of VNS response in depression...
A new randomised controlled trial (RCT)—the “largest ever” of its kind in the major depressive disorder (MDD) space—will attempt to provide a “thorough understanding”...
LivaNova launches new vagus nerve stimulation therapy for drug-resistant epilepsy
LivaNova has launched SenTiva DUO—an implantable pulse generator (IPG) with a dual-pin header intended to provide vagus nerve stimulation (VNS) therapy for patients with...
First commercial Vivistim patient set to begin paired vagus nerve stimulation...
MicroTransponder recently announced the first commercial use of its Vivistim paired vagus nerve stimulation (VNS) system for improved upper-limb function post-stroke. The company said...
RECOVER trial design evaluating vagus nerve stimulation for treatment-resistant depression published
LivaNova announces a publication in Contemporary Clinical Trials, which details the design for a prospective, multicentre, randomised controlled blinded trial demonstrating the safety and...
LivaNova enrols first patient in RECOVER clinical study
LivaNova has announced the first patient enrolled in their RECOVER trial, a prospective, multi-centre, randomised controlled blinded trial demonstrating the safety and effectiveness of...
LivaNova’s VNS Therapy receives FDA approval for expanded MRI labelling
LivaNova’s latest vagus nerve stimulation (VNS Therapy) system has received US Food and Drug Administration (FDA) approval for expanded magnetic resonance imaging labelling.
According...
